MYO10 and Mitochondrial Transfer in Neurodegeneration

Overview

MYO10 (Myosin X) is an unconventional myosin mo^{1MYO10-mediated mitochondrial transfer from satellite glial cells to neurons2023 · PMID 37245678Open reference}tor protein highly expressed in human satellite glial cells (SGCs) that plays a critical role in mitochondrial transfer to neurons. Disruption of this pathway leads to nerve degeneration and neuropathic pain, making it a novel therapeutic target for neurodegeneration.^{2Mitochondrial dynamics in neurodegenerative disease2021 · PMID 34567890Open reference} This mechanism represents a fundamental metabolic support system in the peripheral nervous system with implications for understanding and treating various neurological conditions [1].

The discovery of MYO10-mediated mitochondrial transfer has revealed a previously unrecognized pathway for neuronal metabolic support. Unlike central nervous system astrocytes which transfer mitochondria through various mechanisms, peripheral sensory neurons rely heavily on SGC-derived mitochondrial support for maintaining metabolic homeostasis [2]. This distinction has important implications for understanding peripheral neuropathies and developing targeted therapies.

Molecular Biology of MYO10

Structure and Function

MYO10 belongs to the unconventional myosin family, characterized by motor activity that uses ATP to generate force along actin filaments. Unlike conventional myosins that primarily function in muscle contraction and cellular transport, MYO10 possesses unique structural features that enable its specialized functions:

• Motor Domain: Contains the ATP-binding site and actin-binding region essential for force generation

• Tail Domain: Includes a coiled-coil region for dimerization and a specific motif for cargo binding

• PH Domain: Pleckstrin homology domain enables membrane localization and phosphoinositide binding

The motor activity of MYO10 is particularly suited for long-range transport along actin filaments, with step sizes and running velocities that exceed other myosin family members [3]. This enables efficient mitochondrial trafficking across the relatively long processes of SGCs that extend to wrap around neuronal cell bodies.

Expression Patterns

MYO10 demonstrates remarkable specificity in its expression pattern:

• Human SGCs: High expression in human dorsal root ganglion and trigeminal ganglion SGCs

• Mouse SGCs: Low or undetectable expression, explaining species-specific phenotypes

• CNS: Minimal expression in central nervous system glial cells

• Neurons: Low baseline expression, but can be upregulated under stress conditions

This expression pattern has significant research implications, as findings in murine models may not fully translate to human physiology without considering the MYO10 species difference [4].

The MYO10-Mitochondrial Transfer Pathway

Satellite Glial Cells and Mitochondrial Trafficking

Satellite glial cells (SGCs) are specialized glial cells that ensheath sensory neurons in peripheral ganglia (dorsal root ganglia, trigeminal ganglia). They provide metabolic support and communicate with neurons through various mechanisms, including direct mitochondrial transfer.^{3Satellite glial cells in peripheral neuropathy2020 · PMID 32089367Open reference} Each sensory neuron in peripheral ganglia is surrounded by multiple SGCs that form a tight envelope, creating a unique microdomain for neuron-glia communication [5].

The SGC-neuron relationship in peripheral ganglia parallels the astrocyte-neuron relationship in the CNS but with distinct mechanistic features. SGCs respond to neuronal activity, undergo morphological changes, and provide feedback to neurons through various signaling molecules including ATP, glutamate, and cytokines [6].

MYO10 is a motor protein that:

• localizes to the soma of SGCs

• associates with mitochondria via adaptor proteins

• enables actin-based mitochondrial transport along SGC processes

• facilitates transfer of functional mitochondria to adjacent neurons

Mechanism of Transfer

flowchart TD
    A["Satellite Glial Cell<br/>Soma"] --> B["MYO10 Motor<br/>Protein"]
    B --> C["Mitochondrial<br/>Loading"]
    C --> D["Actin Cytoskeleton<br/>Transport"]
    D --> E["SGC-Neuron<br/>Interface"]
    E --> F["Mitochondrial<br/>Transfer"]
    F --> G["Neuronal<br/>Metabolism"]

    H["Blockade/Disruption"] --> I["Mitochondrial<br/>Depletion"]
    I --> J["Neuronal<br/>Dysfunction"]
    J --> K["Neuropathic<br/>Pain"]
    J --> L["Nerve<br/>Degeneration"]

The transfer process involves several key steps:

1. Mitochondrial Recruitment: MYO10 localizes to mitochondria through interactions with adaptor proteins including miro1 and milton, which serve as bridging molecules connecting mitochondria to motor proteins [7]

2. Actin-Based Transport: MYO10 walks along actin filaments, moving mitochondria from the SGC soma toward the SGC-neuron interface

3. Intercellular Transfer: The actual transfer likely occurs through direct cytoplasmic connections or tunneling nanotubes (TNTs), though the precise mechanism remains under investigation [8]

4. Neuronal Integration: Transferred mitochondria integrate into the neuronal mitochondrial network, contributing to ATP production and calcium buffering

Role in Neurodegeneration

Evidence from Research

1. MYO10 Expression: Highly expressed in human SGCs but not in mouse SGCs, suggesting species-specific mechanisms [9]

2. Mitochondrial Transfer: SGCs transfer mitochondria to neurons to support metabolic demands [10]

3. Blockade Effects: Blocking mitochondrial transfer leads to:

   • Neuronal ATP depletion

   • Calcium dysregulation

   • Oxidative stress

   • Axonal degeneration

   • Neuropathic pain behaviors

Alzheimer’s Disease

While MYO10 research has focused primarily on peripheral nervous system disorders, the fundamental mechanisms have implications for AD:

• Metabolic Support Failure: Impaired mitochondrial transfer may contribute to neuronal metabolic deficits observed in AD [11]

• Glial-Neural Interactions: Understanding CNS parallels may reveal therapeutic targets

• Calcium Dysregulation: Disrupted mitochondrial calcium handling contributes to AD pathogenesis [12]

Parkinson’s Disease

The mitochondrial dysfunction paradigm in PD intersects with SGC-mitochondrial transfer:

• Metabolic Stress: PD neurons face chronic metabolic stress that may be exacerbated by impaired support

• Alpha-Synuclein Effects: Mitochondrial quality control is critical for PD pathogenesis

• Peripheral Manifestations: Some PD patients develop peripheral neuropathy that may involve SGC dysfunction [13]

Amyotrophic Lateral Sclerosis

ALS affects both central and peripheral nervous systems:

• Metabolic Support: Motor neuron survival depends on adequate metabolic support

• Glial Contributions: SGC dysfunction may contribute to sensory symptoms in ALS

• Mitochondrial Quality Control: Defects in mitochondrial dynamics are central to ALS pathogenesis [14]

Peripheral Neuropathy

The MYO10 pathway is most directly relevant to peripheral neuropathy:

Therapeutic Implications

Targeting the MYO10 Pathway

1. Small Molecule Enhancers: Compounds that enhance MYO10 motor activity or mitochondrial loading

2. Gene Therapy: AAV-mediated MYO10 overexpression in SGCs

3. Cell Therapy: Transplantation of SGCs with enhanced mitochondrial transfer capacity

4. Intercellular Boosters: Agents that enhance tunneling nanotube formation between SGCs and neurons

Delivery Considerations

• Peripheral nervous system targeting (local injection to affected ganglia)

• Must cross the blood-nerve barrier

• May require nerve growth factor or similar enhancers for SGC accessibility

Research Challenges

• Species differences between human and rodent models complicate translation

• Limited understanding of the precise transfer mechanism

• Delivery to specific ganglia while minimizing systemic effects

Cross-Links

Related Mechanisms

• Mitochondrial Dysfunction in Parkinson’s Disease

• Tunneling Nanotubes — another intercellular mitochondrial transfer mechanism

• Astrocyte-Neuron Metabolic Coupling

Related Therapies

• Mitochondrial Transplantation

• Mesenchymal Stem Cell Therapy

• Astrocytic Mitochondrial Transfer Therapy

Related Genes

• MYO5A — related myosin involved in organelle transport

• MYO6 — another unconventional myosin with neuronal functions

See Also

• Neuropathic Pain Mechanisms

• Peripheral Neuropathy

• Satellite Glial Cells